CIBC BANK USA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
CIBC BANK USA ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2019$658,000
+6.6%
6,960
-2.1%
0.09%
-1.1%
Q3 2019$617,000
+2.5%
7,109
+7.6%
0.09%
+4.8%
Q2 2019$602,000
+19.4%
6,605
+26.0%
0.08%
+18.3%
Q1 2019$504,000
+12.0%
5,2440.0%0.07%
-2.7%
Q4 2018$450,000
+61.9%
5,244
+52.8%
0.07%
+92.1%
Q1 2018$278,000
+6.9%
3,432
+11.0%
0.04%
+15.2%
Q4 2017$260,000
+0.8%
3,092
+3.0%
0.03%
-2.9%
Q3 2017$258,000
+2.0%
3,002
-0.8%
0.03%0.0%
Q2 2017$253,000
+3.3%
3,027
-8.4%
0.03%0.0%
Q1 2017$245,000
-1.6%
3,306
-3.2%
0.03%
-5.6%
Q4 2016$249,000
-7.8%
3,4170.0%0.04%
-12.2%
Q3 2016$270,000
-3.9%
3,4170.0%0.04%
-6.8%
Q2 2016$281,000
-3.1%
3,417
-14.6%
0.04%
-13.7%
Q1 2016$290,000
-15.7%
4,0010.0%0.05%
-15.0%
Q4 2015$344,000
-33.2%
4,001
-28.5%
0.06%
-36.2%
Q3 2015$515,000
-7.2%
5,597
-0.9%
0.09%
+2.2%
Q2 2015$555,000
-1.1%
5,648
-0.7%
0.09%
-7.1%
Q1 2015$561,000
-29.9%
5,685
-34.1%
0.10%
-29.3%
Q4 2014$800,000
-4.9%
8,633
-3.3%
0.14%
-16.7%
Q3 2014$841,000
+0.5%
8,928
-3.4%
0.17%
+6.3%
Q2 2014$837,000
-0.6%
9,240
-6.7%
0.16%
-9.2%
Q1 2014$842,000
+4.5%
9,905
-1.2%
0.17%
-2.8%
Q4 2013$806,000
-0.5%
10,023
-5.1%
0.18%
-9.6%
Q3 2013$810,000
-77.7%
10,560
-79.4%
0.20%
-7.5%
Q2 2013$3,636,00051,3700.21%
Other shareholders
NOVARTIS A G shareholders Q1 2020
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders